Leo Laboratories Limited

Longwick Road, Princes Risborough, Bucks., HP27 9RR
Telephone: +44 (0)1844 347 333
Fax: +44 (0)1844 276 385
Medical Information e-mail: medical-info.uk@leo-pharma.com
Summary of Product Characteristics last updated on the eMC: 28/10/2008
SPC Dovonex Ointment

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.8 - Undesirable Effects
  • Change to section 5.1 - Pharmacodynamic Properties
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 6. 6 - Instructions for use, handling and disposal
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Oct-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 4.8, undesirable effects have been updated to include frequency details.
Other sections have been updated with the aim of achieving consistency across the product range.
Updated on 18/05/2007 and displayed until 28/10/2008
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 5.3 - Preclinical Safety Data
Date of revision of text on the SPC:   02/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.4: Addition of warning re exposure to sunlight.
Section 4.5: Amendment to wording.
Section 5.3: Information from new studies added.
Updated on 10/11/2003 and displayed until 18/05/2007
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 23/05/2003 and displayed until 10/11/2003
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change to section 10 (date of (partial) revision of the text
Updated on 01/05/2002 and displayed until 23/05/2003
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Updated on 03/08/2001 and displayed until 01/05/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 30/01/2001 and displayed until 03/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 28/01/2000 and displayed until 30/01/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 28/01/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   calcipotriol


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk